Skip to main content
editorial
. 2009 Jan 14;24(4):1088–1096. doi: 10.1093/ndt/gfn728

Table 1.

Validated and hypothetic miRNA targets

Validated miRNA targets in type 2 diabetes and in the endocrine system
miRNA Target Function Reference
miR-375 Myotrophin Inhibition of insulin secretion [69]
miR-9 OneCut2 transcription factor Inhibition of glucose-stimulated insulin release [70]
miR-192 E-box repressors TGF-beta-induced matrix protein collagen Col1a1 and -2 [24]
miR-143 GLUT4, HSL, fatty acid-binding protein aP2, PPAR-μ2 Adipocyte differentiation [49]
Hypothetic miRNA targets associated with type 2 diabetes
miR-30 family Receptor for advanced glycation end product, immediate early response 3, vimentin, heat-shock protein-20 Podocyte apoptosis and cytoskeletal structure [79,80]
miR-23b Hairy/enhancer of the split protein (Hes1) Downstream target of activated Notch signalling and expressed in nephron segments during development [81,84]
miR-15, miR-16 Wnt and β-catenin Nephron induction during embryo development [75,76]
miR-7 GY-box Notch signalling [73,74]
miR-4, miR-79 Brd-box
miR-2, miR-11 K-box